This is a resubmitted application for renewal of an interdisciplinary Drug Abuse Research Training Program, entitled Training in Neuroimmune/Neurobehavior Addiction Research (T32 DA007097-25). This training program has operated for the past 5 years and combines the strengths of two NIDA-funded programs at the University of Minnesota: Training in Drug Abuse and Neurobehavioral Pharmacology (T32 DA07097-20) and Training in PNI and Substance Abuse (T32 DA07239-10). The combined training program meets a well-recognized need to train biomedical scientists at the pre- and postdoctoral levels in an interdisciplinary field that focuses on the interactions of drugs of abuse with the nervous and immune systems, and integrates our understanding of these physiological interactions with their behavioral counterparts. A critical component of the training program considers the role of drugs of abuse as co-factors in HIV/AIDS, specifically relating to NeuroAIDS. Former trainees now hold influential positions in academia, government, and industry. Our 25 faculty primary trainers are a talented group of neuroscientists, psychologists, pharmacologists, immunologists, and microbiologists at the University of Minnesota and affiliated institutions. Across these disciplines we have both laboratory-based scientists and clinical faculty, allowing the program to attract outstanding trainees. The well-funded primary training faculty has extensive experience as mentors and is committed to training predoctoral students and postdoctoral fellows in this interdisciplinary setting. We also have co-mentors with selected expertise that will provide training components and assist in the mentorship of the trainees. To fulfill our training mission with our available resources, we request 10 predoctoral and 5 postdoctoral positions. All of the elements of a successful training program are in place and are functioning well: a formal predoctoral curriculum, including courses in neuro-immune interactions and neuropsychopharmacology;a bimonthly seminar series;and, most importantly, linkages established, collegial, and creative relationships among the faculty across the relevant disciplines. Since the last submission, we have built on our accumulated experience and added two components that will further strengthen our trainees'interdisciplinary translational research experiences: 1) a clinical course on """"""""Substance Abuse to the Bedside"""""""" that focuses on heroin, cocaine/ methamphetamine, nicotine, and the medical complications of addictions, including complications from AIDS, and 2) a new colloquium on """"""""HIV/AIDS: Pathogenesis, Treatment, and Prevention"""""""" led by clinical faculty who deal directly with AIDS patients. (Lay summary) This is a competitive renewal for an interdisciplinary training program at the University of Minnesota that focuses on the interactions of drugs of abuse with the nervous and immune systems, and integrates our understanding of these physiological interactions with their behavioral counterparts, including the role of drugs of abuse as co-factors in HIV/AIDS. To fulfill our training mission, 10 predoctoral and 5 postdoctoral positions are requested.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Other Clinical Sciences
Schools of Veterinary Medicine
United States
Zip Code
Clayton, Jonathan B; Al-Ghalith, Gabriel A; Long, Ha Thang et al. (2018) Associations Between Nutrition, Gut Microbiome, and Health in A Novel Nonhuman Primate Model. Sci Rep 8:11159
Laudenbach, Megan; Baruffaldi, Federico; Robinson, Christine et al. (2018) Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose. Sci Rep 8:5508
Harris, Andrew C; Muelken, Peter; Haave, Zach et al. (2018) Propylene glycol, a major electronic cigarette constituent, attenuates the adverse effects of high-dose nicotine as measured by intracranial self-stimulation in rats. Drug Alcohol Depend 193:162-168
Harris, Andrew C; Muelken, Peter; Smethells, John R et al. (2018) Effects of nicotine-containing and ""nicotine-free"" e-cigarette refill liquids on intracranial self-stimulation in rats. Drug Alcohol Depend 185:1-9
Martin, Jessica L; Mendonça, Luiza M; Marusinec, Rachel et al. (2018) Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly. J Virol 92:
Leavens, Eleanor L S; Meier, Ellen; Tackett, Alayna P et al. (2018) The impact of a brief cessation induction intervention for waterpipe tobacco smoking: A pilot randomized clinical trial. Addict Behav 78:94-100
Swain, Yayi; Muelken, Peter; LeSage, Mark G et al. (2018) Locomotor activity does not predict individual differences in morphine self-administration in rats. Pharmacol Biochem Behav 166:48-56
Chernick, Dustin; Ortiz-Valle, Stephanie; Jeong, Angela et al. (2018) High-density lipoprotein mimetic peptide 4F mitigates amyloid-?-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia. J Neurochem 147:647-662
Claborn, Kasey R; Meier, Ellen; Miller, Mary Beth et al. (2018) Improving adoption and acceptability of digital health interventions for HIV disease management: a qualitative study. Transl Behav Med 8:268-279
Swalve, Natashia; Smethells, John R; Younk, Rebecca et al. (2018) Sex-specific attenuation of impulsive action by progesterone in a go/no-go task for cocaine in rats. Psychopharmacology (Berl) 235:135-143

Showing the most recent 10 out of 261 publications